3-SUBSTITUTED OXINDOLE BETA-3 AGONISTS

The present invention relates to a beta 3 adrenergic receptor agonist of formula I: (I);or a pharmaceutical salt thereof; which is capable of increasing lipolysis and energy expenditure in cells and, therefore, is useful for treating Type 2 diabetes and/or obesity. La présente invention concerne un...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	RUEHTER, GERD, SPINAZZE, PATRICK, GIANPIETRO, FINLEY, DON, RICHARD, BASTIAN, JOLIE, ANNE, STEVENS, FREDDIE, CRAIG, TRANKLE, WILLIAM, GEORGE, JESUDASON, CYNTHIA, DARSHINI, WERNER, JOHN, ARNOLD, RATZ, ANDREW, MICHAEL, ROCCO, VINCENT, PATRICK, HE, JOHN, XIAOQIANG, SALL, DANIEL, JON, SCHOTTEN, THEO
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	AGRICULTURE ANIMAL HUSBANDRY BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES CHEMISTRY FISHING FORESTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HUNTING HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEST REPELLANTS OR ATTRACTANTS PLANT GROWTH REGULATORS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTSTHEREOF SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TRAPPING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a beta 3 adrenergic receptor agonist of formula I: (I);or a pharmaceutical salt thereof; which is capable of increasing lipolysis and energy expenditure in cells and, therefore, is useful for treating Type 2 diabetes and/or obesity. La présente invention concerne un agoniste de récepteur beta 3 adrénergique correspondant à la formule I: (I); ou un sel pharmaceutiquement acceptable de celui-ci, capable d'augmenter la lipolyse et le transport d'énergie dans les cellules; de ce fait, il est utile pour traiter le diabète type 2 et/ou l'obésité.